Skip to content

    10x Genomics (TXG) stock price & financials

    View TXG earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+338.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $151.65M
    $165.02M
    $154.88M
    $172.91M
    $149.00M
    -1.7%
    $166.03M
    +0.6%
    $150.84M
    -2.6%
    $151.04M
    -12.6%
    Weakening
    Operating Profit
    -$41.48M
    -$49.84M
    -$39.33M
    $30.13M
    -$32.24M
    +22.3%
    -$19.54M
    +60.8%
    -$17.05M
    +56.7%
    -$19.55M
    -164.9%
    Weakening
    Net Profit
    -$35.75M
    -$49.03M
    -$34.36M
    $34.54M
    -$27.47M
    +23.2%
    -$16.25M
    +66.9%
    -$13.47M
    +60.8%
    -$17.93M
    -151.9%
    Weakening
    EPS
    $-0.30
    $-0.28
    $0.28
    $-0.22
    +26.7%
    $-0.10
    +64.3%
    $-0.14
    -150.0%
    Weakening
    Other Income
    $7.05M
    $1.46M
    $5.82M
    $6.87M
    $4.04M
    -42.7%
    $4.35M
    +198.0%
    $4.20M
    -27.9%
    $910.0K
    -86.8%
    Strengthening
    Interest
    $2.0K
    $0
    $0
    $3.0K
    -$3.0K
    -250.0%
    $0
    $0
    -100.0%
    Weakening
    Depreciation
    Profit before Tax
    -$34.44M
    -$48.38M
    -$33.51M
    $37.00M
    -$28.20M
    +18.1%
    -$15.19M
    +68.6%
    -$12.85M
    +61.7%
    -$18.64M
    -150.4%
    Weakening
    MarginsOPM
    -27.4%
    -30.2%
    -25.4%
    17.4%
    -21.6%
    +20.9%
    -11.8%
    +61.0%
    -11.3%
    +55.5%
    -12.9%
    -174.3%
    Weakening
    Tax
    -3.8%
    -1.3%
    -2.5%
    6.7%
    2.6%
    -7.0%
    -420.1%
    -4.8%
    -90.9%
    3.8%
    -42.4%
    Weakening
    ReturnsROIC
    2.3%
    3.2%
    2.2%
    -2.2%
    1.8%
    -23.2%
    1.1%
    -66.9%
    0.9%
    -60.8%
    1.2%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$65.08M$424.17M$663.60M$587.45M$219.75M$359.28M$344.07M$473.97M$502.51M
    Short-Term Investments
    Total Current Assets$106.24M$480.84M$774.37M$747.59M$635.03M$596.02M$584.39M$684.45M$674.67M
    Net PP&E$11.13M$48.82M$119.82M$230.41M$359.21M$344.93M$309.94M$287.16M$272.01M
    Goodwill$0$4.51M$4.51M$4.51M$4.51M$4.51M$6.92M
    Intangibles$642.0K$22.37M$22.35M$25.40M$22.86M$16.62M$15.67M$62.33M$61.16M
    Total Assets$124.31M$605.92M$929.34M$1.02B$1.03B$965.14M$918.64M$1.04B$1.03B
    LiabilitiesTotal Current Liabilities$32.36M$63.05M$118.13M$110.36M$130.96M$127.16M$117.63M$153.45M$118.51M
    Short-Term Debt$4.19M$9.88M$0
    Long-Term Debt$25.49M$19.84M$0
    Long-Term Leases$0$57.04M$76.85M$86.14M$83.85M$73.33M$73.38M$66.78M
    Total Liabilities$101.05M$185.84M$190.27M$201.26M$223.24M$224.10M$208.50M$245.04M$204.52M
    EquityCommon Stock & APIC$1.0K$2.0K$2.0K$2.0K$2.0K$2.0K$2.0K$2.0K$2.0K
    Retained Earnings-$231.12M-$262.37M-$805.10M-$863.32M-$1.03B-$1.28B-$1.47B-$1.51B-$1.54B
    Total Equity-$219.99M$420.08M$739.07M$817.57M$805.74M$741.04M$710.13M$796.33M$825.55M
    HighlightsNet Cash / (Debt)$35.40M$394.45M$663.60M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$76.41M$34.63M-$217.90M-$21.37M-$33.61M-$15.20M$6.66M$136.05M$127.08M
    Cash from Investing-$6.71M-$42.77M-$38.39M-$106.73M-$350.89M$133.49M-$32.63M-$13.44M-$19.65M
    Cash from Financing$105.37M$414.59M$468.91M$35.30M$15.82M$13.67M$10.91M$6.80M-$2.54M
    SummaryCapital Expenditure-$6.28M-$42.74M-$36.67M-$101.28M-$131.66M-$48.60M-$12.39M-$5.93M-$5.65M
    Free Cash Flow-$82.69M-$8.12M-$254.56M-$122.65M-$165.27M-$63.80M-$5.73M$130.12M$121.44M
    FCF Margin-56.5%-3.3%-85.2%-25.0%-32.0%-10.3%-0.9%20.2%19.7%

    Ratios